Dyne Therapeutics, Inc.
DYN
$14.20
$0.211.50%
NASDAQ
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Net Income | -42.63% | -34.54% | -41.51% | -36.08% | -45.67% |
Total Depreciation and Amortization | 8.62% | 0.00% | -3.16% | -1.58% | -1.38% |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | 3.81% | 116.51% | 113.11% | 111.04% | 106.06% |
Change in Net Operating Assets | 595.36% | -174.09% | 87.45% | 138.81% | -83.42% |
Cash from Operations | -45.47% | -55.38% | -33.29% | -25.48% | -46.71% |
Capital Expenditure | -358.84% | -225.93% | -18.61% | 31.19% | 63.61% |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | 84.04% | -340.00% | -307.03% | -209.63% | -203.89% |
Cash from Investing | 81.57% | -344.96% | -312.00% | -212.55% | -206.18% |
Total Debt Issued | -- | -- | -- | -- | -- |
Total Debt Repaid | -- | -- | -- | -- | -- |
Issuance of Common Stock | 25.09% | 1,390.92% | 782.49% | 766.93% | 555.56% |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -- | -- | -- | -- | -- |
Cash from Financing | 25.09% | 1,390.92% | 782.49% | 766.93% | 555.56% |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | 121.21% | 720.39% | 2,847.34% | 1,291.43% | 176.20% |